Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an ...

Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an ...

ZURICH (Reuters) - Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an interview on Saturday, with the pharmaceuticals giant ...

Narasimhan is confident that Novartis will achieve its goal of increasing sales by an average of 5% annually by 2028.

By July, Novartis CEO Vas Narasimhan, M.D., was telling investors the company needed to see 48-week data and get “a stronger sense of the overall profile of pelabresib” to finalize its filing ...

For the fourth quarter, Novartis expects Pluvicto performance to be “broadly in line” with Q3, excluding that one-time boost, CEO Vas Narasimhan said during an investor call Tuesday.